Verdence Capital Advisors’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $356K | Buy |
4,175
+28
| +0.7% | +$2.5K | 0.02% | 495 |
|
|
2025
Q4 | $328K | Buy |
4,147
+24
| +0.6% | +$1.88K | 0.02% | 524 |
|
|
2025
Q3 | $321K | Sell |
4,123
-117
| -3% | -$9.98K | 0.02% | 574 |
|
|
2025
Q2 | $385K | Buy |
4,240
+40
| +1% | +$3.65K | 0.03% | 488 |
|
|
2025
Q1 | $394K | Buy |
4,200
+28
| +0.7% | +$2.51K | 0.03% | 461 |
|
|
2024
Q4 | $379K | Sell |
4,172
-265
| -6% | -$25.3K | 0.03% | 419 |
|
|
2024
Q3 | $461K | Buy |
4,437
+13
| +0.3% | +$1.32K | 0.04% | 385 |
|
|
2024
Q2 | $429K | Buy |
4,424
+5
| +0.1% | +$461 | 0.04% | 373 |
|
|
2024
Q1 | $398K | Sell |
4,419
-54
| -1% | -$4.58K | 0.04% | 393 |
|
|
2023
Q4 | $357K | Buy |
4,473
+24
| +0.5% | +$1.8K | 0.03% | 412 |
|
|
2023
Q3 | $316K | Sell |
4,449
-366
| -8% | -$27.4K | 0.03% | 414 |
|
|
2023
Q2 | $371K | Buy |
4,815
+54
| +1% | +$4.18K | 0.04% | 367 |
|
|
2023
Q1 | $358K | Buy |
4,761
+300
| +7% | +$22.3K | 0.04% | 370 |
|
|
2022
Q4 | $351K | Buy |
4,461
+55
| +1% | +$4.12K | 0.04% | 344 |
|
|
2022
Q3 | $310K | Buy |
4,406
+225
| +5% | +$17.6K | 0.04% | 366 |
|
|
2022
Q2 | $335K | Buy |
4,181
+10
| +0.2% | +$782 | 0.04% | 359 |
|
|
2022
Q1 | $316K | Buy |
4,171
+725
| +21% | +$57.4K | 0.04% | 417 |
|
|
2021
Q4 | $294K | Buy |
3,446
+311
| +10% | +$24.3K | 0.03% | 420 |
|
|
2021
Q3 | $237K | Sell |
3,135
-91
| -3% | -$7.23K | 0.03% | 435 |
|
|
2021
Q2 | $262K | Buy |
3,226
+218
| +7% | +$17.8K | 0.04% | 398 |
|
|
2021
Q1 | $237K | Sell |
3,008
-511
| -15% | -$40.1K | 0.04% | 394 |
|
|
2020
Q4 | $301K | Sell |
3,519
-695
| -16% | -$57.5K | 0.06% | 288 |
|
|
2020
Q3 | $325K | Buy |
4,214
+5
| +0.1% | +$381 | 0.07% | 240 |
|
|
2020
Q2 | $308K | Buy |
4,209
+13
| +0.3% | +$923 | 0.08% | 235 |
|
|
2020
Q1 | $278K | Buy |
4,196
+6
| +0.1% | +$423 | 0.08% | 217 |
|
|
2019
Q4 | $288K | Buy |
4,190
+456
| +12% | +$31.1K | 0.07% | 239 |
|
|
2019
Q3 | $274K | Sell |
3,734
-342
| -8% | -$24.8K | 0.08% | 238 |
|
|
2019
Q2 | $292K | Buy |
4,076
+8
| +0.2% | +$568 | 0.08% | 221 |
|
|
2019
Q1 | $279K | Buy |
4,068
+675
| +20% | +$43.6K | 0.08% | 212 |
|
|
2018
Q4 | $202K | Sell |
3,393
-26
| -0.8% | -$1.63K | 0.06% | 227 |
|
|
2018
Q3 | $229K | Sell |
3,419
-203
| -6% | -$13.5K | 0.06% | 236 |
|
|
2018
Q2 | $235K | Buy |
3,622
+19
| +0.5% | +$1.24K | 0.06% | 245 |
|
|
2018
Q1 | $258K | Sell |
3,603
-2
| -0.1% | -$144 | 0.06% | 236 |
|
|
2017
Q4 | $272K | Buy |
+3,605
| New | +$263K | 0.06% | 220 |
|
Other funds holding CL
VCM
DAM
VPM
Verdence Capital Advisors's CL Position: Q1 2026 in Review
Verdence Capital Advisors increased its Colgate-Palmolive (CL) stake by 0.68% in Q1 2026, buying an estimated $2.5K and bringing the position to 4,175 shares worth $356K. The position accounts for 0.02% of the portfolio, ranked #495.
Verdence Capital Advisors first reported a position in CL in Q4 2017 and has held it in 34 quarters since. The position peaked at $461K in Q3 2024. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- Verdence Capital Advisors held 4,175 shares of Colgate-Palmolive worth $356K as of Q1 2026.
- Verdence Capital Advisors bought 28 Colgate-Palmolive shares in Q1 2026, an estimated $2.5K.
- Colgate-Palmolive made up 0.02% of Verdence Capital Advisors's portfolio in Q1 2026, its #495 holding.
- Verdence Capital Advisors first reported a position in Colgate-Palmolive in Q4 2017 and has held it in 34 quarters since.
- Verdence Capital Advisors's Colgate-Palmolive position peaked at $461K in Q3 2024.
- 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on Verdence Capital Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.